Your browser doesn't support javascript.
loading
What is the prevalence of COVID-19 detection by PCR among deceased individuals in Lusaka, Zambia? A postmortem surveillance study.
Gill, Christopher J; Mwananyanda, Lawrence; MacLeod, William B; Kwenda, Geoffrey; Pieciak, Rachel C; Etter, Lauren; Bridges, Daniel; Chikoti, Chilufya; Chirwa, Sarah; Chimoga, Charles; Forman, Leah; Katowa, Ben; Lapidot, Rotem; Lungu, James; Matoba, Japhet; Mwinga, Gift; Mubemba, Benjamin; Mupila, Zachariah; Muleya, Walter; Mwenda, Mulenga; Ngoma, Benard; Nakazwe, Ruth; Nzara, Diana; Pawlak, Natalie; Pemba, Lillian; Saasa, Ngonda; Simulundu, Edgar; Yankonde, Baron; Thea, Donald M.
Afiliação
  • Gill CJ; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA cgill@bu.edu.
  • Mwananyanda L; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • MacLeod WB; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Kwenda G; Biomedical Sciences, University of Zambia, Ridgeway Campus, Lusaka, Lusaka, Zambia.
  • Pieciak RC; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Etter L; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Bridges D; Program for Applied Technology in Health (PATH), Lusaka, Zambia.
  • Chikoti C; Avencion Limited, Lusaka, Zambia.
  • Chirwa S; Avencion Limited, Lusaka, Zambia.
  • Chimoga C; Avencion Limited, Lusaka, Zambia.
  • Forman L; Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts, USA.
  • Katowa B; Macha Research Trust, Choma, Southern Province, Zambia.
  • Lapidot R; Pediatric Infectious Diseases, Boston Medical Center, Brookline, Massachusetts, USA.
  • Lungu J; Avencion Limited, Lusaka, Zambia.
  • Matoba J; Macha Research Trust, Choma, Southern Province, Zambia.
  • Mwinga G; Avencion Limited, Lusaka, Zambia.
  • Mubemba B; Wildlife Sciences, The Copperbelt University, Kitwe, Copperbelt, Zambia.
  • Mupila Z; Avencion, Lusaka, Zambia.
  • Muleya W; Biomedical Sciences, University of Zambia School of Veterinary Medicine, Lusaka, Lusaka, Zambia.
  • Mwenda M; Program for Applied Technology in Health, Lusaka, Zambia.
  • Ngoma B; Avencion Limited, Lusaka, Zambia.
  • Nakazwe R; Biomedical Sciences, University of Zambia University Teaching Hospital, Lusaka, Lusaka, Zambia.
  • Nzara D; Avencion Limited, Lusaka, Zambia.
  • Pawlak N; Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Pemba L; Avencion Limited, Lusaka, Zambia.
  • Saasa N; University of Zambia School of Veterinary Medicine, Lusaka, Zambia.
  • Simulundu E; Macha Research Trust, Choma, Southern Province, Zambia.
  • Yankonde B; Avencion Limited, Lusaka, Zambia.
  • Thea DM; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
BMJ Open ; 12(12): e066763, 2022 12 06.
Article em En | MEDLINE | ID: mdl-36600354
OBJECTIVES: To determine the prevalence of COVID-19 postmortem setting in Lusaka, Zambia. DESIGN: A systematic, postmortem prevalence study. SETTING: A busy, inner-city morgue in Lusaka. PARTICIPANTS: We sampled a random subset of all decedents who transited the University Teaching Hospital morgue. We sampled the posterior nasopharynx of decedents using quantitative PCR. Prevalence was weighted to account for age-specific enrolment strategies. INTERVENTIONS: Not applicable-this was an observational study. PRIMARY OUTCOMES: Prevalence of COVID-19 detections by PCR. Results were stratified by setting (facility vs community deaths), age, demographics and geography and time. SECONDARY OUTCOMES: Shifts in viral variants; causal inferences based on cycle threshold values and other features; antemortem testing rates. RESULTS: From 1118 decedents enrolled between January and June 2021, COVID-19 was detected among 32.0% (358/1116). Roughly four COVID-19+ community deaths occurred for every facility death. Antemortem testing occurred for 52.6% (302/574) of facility deaths but only 1.8% (10/544) of community deaths and overall, only ~10% of COVID-19+ deaths were identified in life. During peak transmission periods, COVID-19 was detected in ~90% of all deaths. We observed three waves of transmission that peaked in July 2020, January 2021 and ~June 2021: the AE.1 lineage and the Beta and Delta variants, respectively. PCR signals were strongest among those whose deaths were deemed 'probably due to COVID-19', and weakest among children, with an age-dependent increase in PCR signal intensity. CONCLUSIONS: COVID-19 was common among deceased individuals in Lusaka. Antemortem testing was rarely done, and almost never for community deaths. Suspicion that COVID-19 was the cause of deaths was highest for those with a respiratory syndrome and lowest for individuals <19 years.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos